Passionate and Astute Entrepreneurial Executive with Experience in Developing and Executing Growth Strategies


Pharmaceutical Services Business Development

Outsourcing Strategies

Quality Systems; Compliance Excellence

Innovation Strategies

Building High Performing Teams

Operational Excellence – Lean Processes

Compliance & Persistency Strategies

Organizational Restructuring Serialization Management 


xCell Strategic Consulting -

Aphena Pharma Solutions – President & CEO

Schott Pharma Systems – Vice President & GM

Cardinal Health/ Catalent – Group President, Packaging


Former Board of Director, Chairman, Healthcare Compliance Packaging Council (HCPC)


BS, Chemistry, University of Massachusetts

Leadership Courses, Boston University, School of Management





Renard Jackson, Principal Consultant

Global Operating and Sales Management Executive successful at building high-performance executive teams and leading sophisticated service organizations with P&L responsibility up to $470MM.  A strategic and innovative visionary, with a clear sense of purpose and urgency when faced with diverse situational challenges. Skilled at establishing operational excellence within a Pharmaceutical and Medical Device cGMP environment, translating conceptual models into specific growth strategies, and planning/executing multi-faceted global business development campaigns designed to improve market share, gross revenue and EBITDA.

Renard has been involved in major operational restructuring, has driven significant network wide improvements in Quality, Cost and Customer Service and has turned around underperforming factories.  He has broad capabilities in driving change and managing Manufacturing and Supply Chain Operations.


  • Significantly improved market share and grew revenue 53% from $49M to $75M in three years at a mid-size specialty pharma manufacturer.
  • Instituted new sales strategies, controls and metrics, and transitioned the sales function from a product to a solution focus.
  • Developed new strategies aimed at entering the expanding North American sterile syringe market by building a new sterile syringe filling operation to support the strategy.
  • Pioneered Anti-counterfeit and Serialization/ Track & Trace technology by developing and sponsoring the industry’s first end-to-end pilot for Barcode and RFID tag technology to test effectiveness, cost and ROI.